Top

Journal of Medical Case Reports

Published in:

Open Access 01-12-2015 | Case report

Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report

Authors: Aloys Lallement, Christine Zandotti, Philippe Brouqui

Published in: Journal of Medical Case Reports | Issue 1/2015

Abstract

Introduction

According to some studies, ascorbic acid possesses antiviral properties. These studies were mainly focused on the common cold, with very few focusing on other viral infections.

Case presentation

We report the case of a 54-year-old Caucasian woman with chronic arthralgia due to persistent parvovirus B19 viremia. High doses of ascorbic acid treatment were initiated due to the failure of conventional analgesic therapy. Clinical benefit was observed with a simultaneous loss of biological parvovirus B19 viremia.

Conclusions

This observation shows a potential benefit of the use of ascorbic acid against parvovirus B19 infections, even if this case is not sufficient to draw any definite conclusions.

Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, Caul O, Dieppe PA: Clinical manifestations of human parvovirus B19 in adults.Arch Intern Med 1989, 149:1153–1156. 10.1001/archinte.1989.00390050111022CrossRefPubMed

Hemilä H, Chalker E: Vitamin C for preventing and treating the common cold.Cochrane Database Syst Rev 2013., 1: CD000980

Stephenson C, Levin D, Spector T, Lis G: Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.Cancer Chemother Pharmacol 2013, 72:139–146. 10.1007/s00280-013-2179-9CrossRefPubMedPubMedCentral

Mikirova N, Hunninghake R: Effect of high dose vitamin C on Epstein-Barr viral infection.Med Sci Monit 2014, 20:725–732.CrossRefPubMedPubMedCentral

Schencking M, Vollbracht C, Weiss G, Lebert J, Biller A, Goyvaerts B, Kraft K: Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohirt study.Med Sci Monit 2012, 18:215–224.CrossRef

Franssila R, Hedman K: Infection and musculoskeletal conditions: viral causes of arthritis.Best Pract Res Clin Rheumatol 2006, 20:1139–1157. 10.1016/j.berh.2006.08.007CrossRefPubMed

Heegaard ED, Brown KE: Human parvovirus B19.Clin Microbiol Rev 2002, 15:485–505. 10.1128/CMR.15.3.485-505.2002CrossRefPubMedPubMedCentral

Gallinella G: Parvovirus B19 achievements and challenges.ISRN Virology 2013, 2013:898730.CrossRef

Bozzola E, Krzysztofiak A, Cortis E: Neurological impairment and arthritis in an immunocompetent child with human parvovirus B19 chronic infection.Infez Med 2010, 18:187–190.PubMed

10.

Jacobson SK, Daly JS, Thorne GM, McIntosh K: Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review.Clin Infect Dis 1997, 24:1048–1051. 10.1086/513627CrossRefPubMed

11.

Frickhofen N, Abkowitz JL, Safford M, Berry JM, Antunez-de-Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young NS: Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.Ann Intern Med 1990, 113:926–933. 10.7326/0003-4819-113-12-926CrossRefPubMed

12.

Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL: Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.BR J Haematol 1994, 87:818–824. 10.1111/j.1365-2141.1994.tb06743.xCrossRefPubMed

13.

Koduri PR, Kumapley R, Valladares J, Teter C: Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.Am J Hematol 1999, 61:16–20. 10.1002/(SICI)1096-8652(199905)61:1<16::AID-AJH4>3.0.CO;2-YCrossRefPubMed

14.

Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blease RM, Young NS: Immune response to B19 parvovirus and an antibody defect in persistent viral infection.J Clin Invest 1989, 84:1114–1123. 10.1172/JCI114274CrossRefPubMedPubMedCentral

15.

Stahl HD, Pfeiffer R, Emmrich F: Intravenous treatment with immunoglobulins may improve chronic undifferentiated mono- and oligoarthritis.Clin Exp Rheumatol 2000, 18:515–517.PubMed

16.

Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furusyo N, Hayashi J: Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection.J Infect Chemother 2008, 14:377–382. 10.1007/s10156-008-0636-XCrossRefPubMed

17.

Saag KG, True CA, Naides SJ: Intravenous immunoglobulin treatment of chronic parvovirus B19 arthropathy.Arthritis Rheum 1993,36(Suppl):S67.

18.

Bönsch C, Kempf C, Mueller I, Manning L, Laman M, Davis TM, Ros C: Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.PLoS Negl Trop Dis 2010, 4:e669. 10.1371/journal.pntd.0000669CrossRefPubMedPubMedCentral

Title: Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report
Authors: Aloys Lallement
Christine Zandotti
Philippe Brouqui
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Journal of Medical Case Reports / Issue 1/2015
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/1752-1947-9-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report

Abstract

Introduction

Case presentation

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Prolapse of fallopian tube through abdominal wound after caesarean section mimicking scar endometriosis: a case report

Reconstruction of advanced bone defect associated with severely compromised maxillary anterior teeth in aggressive periodontitis: a case report

Ortner’s syndrome presenting as thoracic aortic aneurysm mimicking thoracic malignancy: a case report

Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report

Life-threatening pleural hemorrhage following intrapleural enzyme therapy and successful treatment with fibrin-thrombin sealant pleurodesis: a case report

Pathology characteristics of ocular von Hippel-Lindau disease with neovascularization of the iris and cornea: a case report